Friedreich Ataxia Scientific News

Friedreich Ataxia and close related scientific news. Topics related to rare diseases.

Tuesday, December 23, 2025

Respiratory Function in Friedreich's Ataxia

›
Viana CF, Jaques CS, Bezerra MLE, Barsottini OGP, Pedroso JL. Respiratory Function in Friedreich's Ataxia. Mov Disord. 2025 Dec 19. doi:...

Ferroptosis is a novel pathogenic mechanism of FDXR-related disease via disruption of the NRF2 pathway

›
Campbell, T., Slone, J., Vu, J. et al. Ferroptosis is a novel pathogenic mechanism of FDXR-related disease via disruption of the NRF2 pathwa...
Saturday, December 20, 2025

Targeting Friedreich Ataxia: A Sustainable Path to Safer and Smarter Therapeutics Through Integrated Docking and Toxicology

›
H. B. Attel, R. P, A. K, B. S, Shivandappa and S. Manokaran, "Targeting Friedreich Ataxia: A Sustainable Path to Safer and Smarter Ther...
Wednesday, December 17, 2025

The NCPE recommends that omaveloxolone not be considered for reimbursement

›
NCPE assessment completed, 16/12/2025. The National Centre for Pharmacoeconomics (NCPE) is a team of experts who look at the health benefits...
Sunday, December 14, 2025

Cross-regulation of [2Fe–2S] cluster synthesis by ferredoxin-2 and frataxin

›
Want, K., Gorny, H., Turki, E. et al. Cross-regulation of [2Fe–2S] cluster synthesis by ferredoxin-2 and frataxin. Nature (2025). doi: 10.10...
Thursday, December 11, 2025

Mutations in mitochondrial ferredoxin FDX2 suppress frataxin deficiency

›
Meisel, J.D., Joshi, P.R., Spelbring, A.N. et al. Mutations in mitochondrial ferredoxin FDX2 suppress frataxin deficiency. Nature (2025). do...
Wednesday, December 10, 2025

Eli Lilly (LLY) Completes Acquisition of Adverum Biotechnologies

›
Eli Lilly (LLY) Completes Acquisition of Adverum Biotechnologies. GuruFocus News 12/09/2025.  This acquisition enhances Eli Lilly's port...
Sunday, December 7, 2025

Solid Biosciences Receives FDA Rare Pediatric Disease Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia

›
CHARLESTOWN, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. today announced that it received Rare Pediatric Disease designa...

Enhancing the Objective Assessment of Friedreich Ataxia Severity: A Multiview IMU-Based Approach

›
Ranaweera K, Nguyen BA, Pathirana PN, Milne SC, Horne M, Delatycki MB, Corben LA. Enhancing the Objective Assessment of Friedreich Ataxia Se...
Saturday, December 6, 2025

Reliable Objective Assessment of Friedreich Ataxia Through Isolation Forest-Based Anomaly Detection

›
Ranaweera K, Randeniya M, Pathirana PN, Milne SC, Horne M, Delatycki MB, Corben LA. Reliable Objective Assessment of Friedreich Ataxia Throu...
‹
›
Home
View web version

About Me

My photo
Juan Carlos Baiges
Tortosa, Catalunya, Spain
BSc, MSc (Pharmacy), MSc (Computer science)
View my complete profile
Powered by Blogger.